The clinic’s CEO said the technology “holds tremendous promise in revolutionizing healthcare and expediting progress toward new cares, cures and solutions for patients.” IBM’s CEO added that “By combining the power of quantum computing, artificial intelligence and other next-generation technologies with Cleveland Clinic’s world-renowned leadership in healthcare and life sciences, we hope to ignite a new era of accelerated discovery.”
em>Inside HPC points out that “IBM Quantum System One” is part of a larger biomedical research program applying high-performance computing, AI, and quantum computing, with IBM and the Cleveland Clinic “collaborating closely on a robust portfolio of projects with these advanced technologies to generate and analyze massive amounts of data to enhance research.”
The Cleveland Clinic-IBM Discovery Accelerator has generated multiple projects that leverage the latest in quantum computing, AI and hybrid cloud to help expedite discoveries in biomedical research. These include:
– Development of quantum computing pipelines to screen and optimize drugs targeted to specific proteins;
– Improvement of a quantum-enhanced prediction model for cardiovascular risk following non-cardiac surgery;
– Application of artificial intelligence to search genome sequencing findings and large drug-target databases to find effective, existing drugs that could help patients with Alzheimer’s and other diseases.
The Discovery Accelerator also serves as the technology foundation for Cleveland Clinic’s Global Center for Pathogen & Human Health Research, part of the Cleveland Innovation District. The center, supported by a $500 million investment from the State of Ohio, Jobs Ohio and Cleveland Clinic, brings together a team focused on studying, preparing and protecting against emerging pathogens and virus-related diseases. Through the Discovery Accelerator, researchers are leveraging advanced computational technology to expedite critical research into treatments and vaccines.
Read more of this story at Slashdot.